Furthermore, SVIP is upregulated in the presence of ZAAT and inhibits ERAD through gp78-p97/VCP interaction, leading to increased ZAAT accumulation and AATD-associated liver disease. Here, SVIP is linked to alpha 1-antitrypsin deficiency.